RPD Fund Opens Hefty $100 Million Position in Nice Stock Amid AI Worries

RPD Fund Management initiated a new position in NICE of 886,005 shares valued at $100.15M, representing 43.42% of its 13F-reportable U.S. equity AUM as of Dec 31, 2025. NICE was trading at $118.28 on Mar 19, 2026 (down 21.7% Y/Y); company metrics include TTM revenue $2.97B, net income $617.08M, cloud sales +13% in 2025, cloud backlog +25%, and AI product ARR growth of 66% in the last quarter. The piece highlights a contrarian bullish view (15x free cash flow valuation, aggressive buybacks and Cognigy acquisition) that could support upside for NICE but remains speculative given recent sector selling on AI disruption concerns.

Analysis

A concentrated, conviction-weighted buy shifts the market microstructure around NICE more than it changes the company’s fundamentals. In the near term (days–weeks) expect tighter liquidity and asymmetric flows that can amplify moves on earnings or guidance, while over months the true test will be backlog conversion and enterprise retention as customers adopt AI-enabled CX modules.

Competitive dynamics favor vendors that can monetize recurring analytics and compliance features at scale; incumbents that stitch AI into mission-critical workflows increase switching costs and raise TAM per customer. This should pressure smaller point players that rely on ad hoc integrations, and indirectly benefits cloud compute and GPU suppliers as enterprises migrate inference/LLM workloads from pilots to production.

Key risks are execution and multiple compression: failed integrations, rising churn, or a macro downturn can unwind sentiment quickly — most likely within 1–4 quarters. Positive catalysts that would re-rate the stock are sustained ARR acceleration from AI modules, a clear cadence of backlog-to-revenue conversion over two consecutive quarters, or a sizable buyback/return program that meaningfully tightens float.

From a portfolio-construction standpoint, the move creates both a tactical volatility opportunity and a structural crowding risk. If you want exposure, scale it as a participation trade with defined hedges; if you prefer to express skepticism, look for pairs or selective shorts that isolate execution risk versus AI-beta.

Key Decisions for Investors

• Long NICE (NICE) — allocate 1–2% NAV in equity or a synthetic long (buy 12-month near-the-money call + sell 12-month 40% OTM call to finance) with a 12–18 month horizon; target 40–80% upside if ARR conversion sustains, hard stop or hedge with a 20–25% protective put to limit downside to ~20%.
• Pair trade: long NICE (NICE) / short Appian (APPN) equal notional — 6–12 month horizon to isolate execution vs AI-beta; expected payoff if NICE demonstrates enterprise retention and APPN lags in monetization; cap portfolio exposure to 1% NAV net and hedge sector drawdowns with a small index put (SPX).
• Options asymmetry: buy 9–12 month NICE call spread (buy ATM, sell 50% OTM) sized to 0.5–1% NAV to capture upside while limiting premium outlay; breakeven requires ~30–40% move, max loss = premium paid, skew favors asymmetry if liquidity tightens.
• Short candidate (selective): identify high-valuation, low-FCF AI-adjacent CX names without durable enterprise contracts (e.g., pure-play visualization or analytics vendors) for a 3–9 month tactical short — size small, use monthly puts to express thesis, and watch for sector-wide liquidity squeezes that can create sharp, temporary losses.